COPSAC COPSAC COPSAC COPSAC
  • About COPSAC
    • About
    • Organization Diagram
    • Board of Directors
    • Research team
    • Location
    • Funding
    • Logo
    • Open positions
  • COPSAC cohorts
    • COPSAC2000 cohort
    • COPSAC2010 cohort
    • COPSACSEVERE cohort
    • COPSACACUTE cohort
    • Methods
    • Data overview
      • COPSAC2000 Clinic
      • COPSAC2000 Exposures
      • COPSAC2000 Omics
      • COPSAC2000 Biobank
      • COPSAC2010 Clinic
      • COPSAC2010 Exposures
      • COPSAC2010 Omics
      • COPSAC2010 Biobank
  • Dissemination
    • Theses
    • Literature for parents
  • Research Projects
    • RestoreGut
    • COPSYCH Research Alliance
    • HEDIMED Consortium
    • EDIAQI Consortium
    • EAGLE Consortium
    • EarlyVir
  • Strategy
  • ‌

2006 Liselotte B Halkjær, MD, PhD

  • 2015 Ann-Marie Malby Schoos, MD PhD
    • Thesis_2015_Ann-Marie_Schoos
  • 2014 Marie Kragh, MSc PhD
    • Thesis_2014_Marie-Kragh.pdf
  • 2014 Eskil Kreiner-Møller, MD PhD
    • Thesis_2014_Eskil-Kreiner-Moller
  • 2014 Nadja Hawwa Vissing, MD PhD
    • Thesis_2014_Nadja-Vissing
  • 2014 Anna Hammerich Thysen, Msc PhD
    • Thesis_2014_Anna-Thysen
  • 2013 Charlotte Giwercman Carson MD, PhD
    • Thesis_2013_Charlotte-Giwercman
  • 2013 Anne Louise Bischoff MD, PhD
    • Thesis_2013_Anne-Bischoff
  • 2012 Louise Pedersen, MD, PhD
    • Thesis_2012_Louise-Pedersen
  • 2012 Jakob Stokholm, MD, PhD
    • Thesis_2012_Jakob-Stokholm
  • 2012 Nilofar Følsgaard, MD, PhD
    • Thesis_2012_Nilo-Foelsgaard
  • 2011 Martin Brasholt, MD, PhD
    • Thesis_2011_Martin-Brasholt
  • 2011 Bo Chawes, MD, PhD
    • Thesis_2011_Bo-Chawes
  • 2010 Klaus Bønnelykke, MD, PhD
    • Thesis_2010_Klaus-Bonnelykke
  • 2010 Porntiva Poorisrisak, MD, PhD
    • Thesis_2010_Porntiva-Poorisrisak
  • 2009 Mette N Hermansen, MD, PhD
    • Thesis_2009_Mette-Hermansen
  • 2006 Liselotte B Halkjær, MD, PhD
    • Thesis_2006_Liselotte-Halkjær
  • 2006 Birgitte Boysen Kjær, MD, PhD
  • 2004 Lotte Loland, MD, PhD
    • Thesis_2004_Lotte-Loland
  • 2002 Frederik F Buchvald, MD, PhD
    • Thesis_2002_Frederik-Buchvald
  • 1999 Marianne Stubbe Østergaard, MD, PhD
  • 1993 Jytte Fogh, MD, PhD
  • 2017 Elín Bjarnadóttir, MD PhD
  • 2017 Helene Wolsk, MD
  • 2017 Tine Marie Pedersen, MD
  • 2017 Astrid Sevelsted, MSc
  • 2017 Rebecca Kofod Vinding, MD
  • 2019 Lambang Arianto, MD
  • 2018 Henrik Hallas, MD
  • 2018 Jonathan Thorsen, MD
  • 2018 Nadia Rahman Fink, MD
  • 2019 Christian Carlsson, MD
  • 2019 Christian Carlsson, MD
  • 2019 Ni Wang, MD
  • 2021 Sarah Nørgaard – MSc
  • 2020 Asja Kunøe – MD
  • 2021 Nicklas Brustad – MD
  • 2021 Anders Eliasen – MSc
  • 2021 Lærke Sass – MD
  • 2022 Pia Nørrisgaard – MSc
  • 2022 Emil Christensen – MD
  • 2023 Rikke Sunde – MD
  • 2023 Julie Kyvsgaard – MD
  • 2024 Yang Luo – MSc
  • 2024 Julie Rosenberg – MD
  • 2024 Christina Poulsen – MSc
  • 2024 Parisa Mohammadzadeh – MD
  • 2024 Signe Jensen – MD
  • 2024 David Horner – MD
  • 2025 Liang Chen
  • 2025 Sarah Brandt
Home Home Dissemination Theses 2006 Liselotte B Halkjær, MD, PhD

Predictors and Risk Factors for Atopic Dermatitis in Early Infancy

By Liselotte B Halkjær, MD, PhD

Summary

Chairman: Henrik Permin

Opponent: Carsten Bindslev-Jensen

Opponent: Kirsten Skamstrup Hansen

(PDF)

The primary aim of the thesis was to describe the development of atopic dermatitis (AD) during the first three years of life by describing the progressively changing skin lesion pattern of AD over time; to study the severity progression of AD over three years´ time; and to identify the localization of the early skin lesions that predicts the development of AD by the age of three years.

The secondary aim was to identify prenatal and perinatal risk factors for AD by the age of three years with respect to heredity, social status, preconception variables, prenatal complications, prenatal exposures and birth variables.

The study was based on the COPSAC (COPenhagen Study on Asthma in Childhood) cohort, a prospective longitudinal birth-cohort of children, born of mothers with asthma. The children were followed for three years with scheduled visits every six months as well as acute visits for skin symptoms. The cohort was recruited from Greater Copenhagen and followed at a clinical research unit, which controlled all diagnosis and treatment. 411 infants were included in the cohort; 55 had incomplete follow-up and were excluded from the analysis. AD diagnosis was based on the Hanifin and Rajka criteria, and AD severity assessed by SCORAD. Predictive odds-ratios of early skin lesions for those who developed AD versus those who did not were calculated. Heredity, prenatal and perinatal questionnaire-based factors were obtained by interview of the mother and father. Preliminary univariate Odds ratio estimates from logistic regression of AD development by three years of age were presented for heredity, prenatal and perinatal risk factors.

The cumulative incidence of AD by three years of age was 44% (155/356). The prevalence rate for boys peaked at two and for girls at 2½ years of age, but there was no gender difference in the proportion of children developing AD. Skin involvement in AD-infants was found to begin at the scalp, forehead, ear, and neck like a balaclava, and continue to the extensor sides of the extremities, trunk and finally the flexor sides of the extremities. Most infants presented mild to moderate AD and no obvious gender difference was seen in severity. The severity of AD generally declined with age. Early skin lesions of arms and joints best predicted AD at the age of three years.

The study revealed maternal AD, maternal history of hand eczema and paternal asthma, allergic rhinitis and inhalant-allergy as the strongest genetic risk factors (of the atopy diseases) for developing AD by the age of three years.

Maternal limited exercise during 3rd trimester and alcohol intake in pregnancy as well as short birth length (of otherwise full term children) dominated as significant prenatal and perinatal risk factors for AD development by the age of three years.

The COPSAC cohort is a birth cohort of children at high-risk for developing atopic diseases including AD. This selection restricts how the findings may be generalized, and validation in unselected populations may be needed. This thesis aimed to explore predictors and risk factors for atopic dermatitis in early infancy, which may allow early intervention and hope for prevention strategies in the future.


CONTACT

COPSAC
Copenhagen Prospective Studies on Asthma in Childhood
Copenhagen University Hospital, Herlev-Gentofte
phone +45 3867 7360
contact@copsac.com
COPSAC • Copenhagen University Hospital, Herlev-Gentofte • Denmark © 2023
  • About COPSAC
    • About
    • Organization Diagram
    • Board of Directors
    • Research team
    • Location
    • Funding
    • Logo
    • Open positions
  • COPSAC cohorts
    • COPSAC2000 cohort
    • COPSAC2010 cohort
    • COPSACSEVERE cohort
    • COPSACACUTE cohort
    • Methods
    • Data overview
      • COPSAC2000 Clinic
      • COPSAC2000 Exposures
      • COPSAC2000 Omics
      • COPSAC2000 Biobank
      • COPSAC2010 Clinic
      • COPSAC2010 Exposures
      • COPSAC2010 Omics
      • COPSAC2010 Biobank
  • Dissemination
    • Theses
    • Literature for parents
  • Research Projects
    • RestoreGut
    • COPSYCH Research Alliance
    • HEDIMED Consortium
    • EDIAQI Consortium
    • EAGLE Consortium
    • EarlyVir
  • Strategy
  • ‌
COPSAC